Menu Back toSESSION-2-PANEL-DISCUSSION
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
4th DIA Cell and Gene Therapy Products Symposium in Japan
All prices are exclusive of 10% Japanese consumption tax
SESSION 2 - PANEL DISCUSSION
- Principle, Regulatory Affairs Group, Post-Marketing Regulatory Affairs Dept.
- Daiichi Sankyo Co., Ltd., Japan
Daisaku Sato, PhD, MPharm, RPh
- Director, Compliance & Narcotics Division
- Ministry of Health, Labour and Welfare, Japan